Overview

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Status:
Terminated
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the study drug is effective and safe in the first line treatment of patients with small cell lung cancer
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
Treatments:
Epothilones
Sagopilone